Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service company that is focused on acquiring and developing early-stage technologies. The Company is engaged in the business of health data and point-of-care technologies (POCT). It provides digital solutions that support the role of pharmacists and provide infrastructure for making clinical services more accessible and more affordable in its communities. The Company's offering includes HealthTab. HealthTab is a cloud-based network technology that enables the real-time response system where consumers receive a finger-stick blood test at their local pharmacy via a Web-enabled blood chemistry analyzer. Its HealthTab platform can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. It also provides bacterial and viral testing for Strep and COVID-19. The Company's wholly owned subsidiary is HealthTab Inc.


TSXV:AVCR - Post by User

Bullboard Posts
Post by pennyDoctoron May 26, 2016 6:31pm
203 Views
Post# 24908395

NEWS

NEWSWell it figures that those that recieved paper and would have had the paper expire worthless are now given an early XMAS gift.  NPH has dropped the exercise price and extended the period for 6 months.  I guess they need the cash or they have a heavy hitter in their back pocket that needed to be satisfied.  

The Bad...
Managment should know this is sleazy work and if it was just to get the few million in the door they are favoring a few at the risk of psssng off the many.
The Good...
None the less the price has to climb past $.40 to make this work so we will be further in the money than we are now.  
Further more they are not announcing another financing just extending what is already out there.

Lets get on with it. 
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse